In patients with T2DM and chronic liver disease attributed to MASLD, the risk of major adverse liver outcomes after GLP-1RA treatment over 10 years fails to decrease (15.8% vs
Tirzepatide, a dual GIP/GLP-1 receptor agonist, powers both Mounjaro (diabetes) and Zepbound (weight management)
For individuals seeking reliable weight loss solutions, Wegovy stands out as a safer, more predictable option
In this blog, we will understand how okra water is made and its nutritional value, possible benefits, and side effects
This combined activation mechanism stimulates insulin secretion while concurrently increasing energy expenditure via glucagon pathways
pharmaceutical giant Eli Lilly has developed an oral medication called orforglipron